Search Results 51-60 of 12047 for Lupus
Safety, Efficacy and Tolerability of Ianalumab Versus Placebo, Combination With SoC Therapy, in Participants With Active Lupus Nephritis ... Lupus Nephritis (LN).
... Lupus is a chronic inflammatory disease that occurs when your body's immune ... lupus can affect many different body systems — including your joints ...
Lupus was wreaking havoc on Emily Olson's health. Her Mayo Clinic care team's decision to employ a medication typically not used for this autoimmune disorder, ...
Anifrolumab-fnia injection is used to treat moderate to severe systemic lupus erythematosus (SLE) in patients who are also receiving other lupus treatments.
... Lupus Erythematosus: A Study From Lupus ... Fragility of randomised controlled trials for systemic lupus erythematosus and lupus nephritis therapies.
This study aims to evaluate the efficacy and safety of subcutaneous (SC) anifrolumab versus placebo in adult participants with cutaneous lupus erythematosus ( ...
The purpose of this study is to evaluate the safety and tolerability of CABA-201 in subjects with active Systemic Lupus Erythematosus. Participation eligibility.
Lupus rash. Lupus is an inflammatory disorder that affects a number of body systems. One symptom is the appearance of a bumpy rash on skin exposed to ...
... Lupus International Collaborating Clinics (SLICC) criteria for diagnosis of lupus ... Has active Central nervous system (CNS) lupus or history of severe CNS lupus ...
Blood cancers. Immune system diseases, such as rheumatoid arthritis, lupus and scleroderma. Reactions to certain medicines. Risk factors. Vasculitis can happen ...
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Make a gift before July 31 and it can be doubled in impact thanks to a $100,000 Summer Challenge.